Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 185

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 185
---
    100,164 (7 | ) |     | *             |
| Ajay Raju                                                                   |     |  2,006,250 (8 | ) |     | 9.8%          |
| William L. Ashton                                                           |     |     47,500 (9 | ) |     | *             |
| Robert J. Ciaruffoli                                                        |     |    58,750 (10 | ) |     | *             |
| Larry Kaiser                                                                |     |    46,250 (11 | ) |     | *             |
| Barry Fishman                                                               |     |    46,250 (12 | ) |     | *             |
| Sara R. May                                                                 |     |    46,250 (13 | ) |     | *             |
| Hon. Cathy McMorris Rodgers                                                 |     |     6,250 (14 | ) |     | *             |
| Patrick J. Mahaffy                                                          |     |        35,435 |   |     | *             |
| All officers and directors as a group (14 individuals)                      |     |     4,293,824 |   |     | 19.9%         |
| Five Percent Holders of Medicus Pharma Ltd. (other than those listed above) |     |               |   |     |               |
| Dr. Kenneth Melani                                                          |     | 3,248,741 (15 | ) |     | 15.9%         |

* Less than one percent.

(1)Unless otherwise noted, the business address of each of our directors and executive officers is 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

<div align='center'>130</div>

(2)Includes 793,173 common shares held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Includes 362,500 common shares underlying stock options that are currently exercisable.

(3)Includes 12,500 common shares underlying stock options and 24,000 common shares underlying Public Warrants that are currently exercisable or will become exercisable.

(4)Includes 85,000 common shares underlying stock options that are currently exercisable.

(5)Includes 107,500 common shares underlying stock options and 24,000